Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic and biliary autoantigens.

I R Mackay1

  • 1Centre for Molecular Biology and Medicine, Monash University, Melbourne, Victoria, Australia.

Immunological Investigations
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes.

Autoimmunity·2003
Same author

Humanism and the suffering of the people.

Internal medicine journal·2003
Same author

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same author

A dietary cause of type 1 diabetes: unearthing a new twist to the tale.

Diabetes technology & therapeutics·2002
Same author

Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.

Journal of gastroenterology and hepatology·2002
Same author

Dietary microbial toxins and type 1 diabetes--a new meaning for seed and soil.

Diabetologia·2001
Same journal

Riboflavin Modulates Complement Activation, Immune Cell Viability and Activation, and Neutrophil Microbicidal Functions <i>in Vitro</i>.

Immunological investigations·2026
Same journal

Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.

Immunological investigations·2026
Same journal

Nanoantibodies: A Review of Diagnostic and Therapeutic Applications in Respiratory Diseases.

Immunological investigations·2026
Same journal

TRIM31: A Novel Guardian Against Periodontal Inflammation via Modulation of NLRP3 Inflammasome and Macrophage Polarization.

Immunological investigations·2026
Same journal

LincRNA-Cox2 in Inflammation: Regulatory Networks, Experimental Insights, and Future Directions.

Immunological investigations·2026
Same journal

Mechanical Regulation of the Immune System: From Sensory Mechanisms to Disease Pathogenesis.

Immunological investigations·2026
See all related articles

Autoimmune liver diseases like chronic active hepatitis and primary biliary cirrhosis involve specific autoantigens. Researchers identified key antigens in PBC, including the E2 component of pyruvate dehydrogenase, crucial for disease understanding.

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Chronic active hepatitis (CAH) and primary biliary cirrhosis (PBC) are complex liver diseases with suspected autoimmune involvement.
  • Differentiating autoimmune CAH (A-CAH) from other forms requires understanding specific autoantigens.
  • Autoimmunity plays a significant role in the pathogenesis of these liver conditions.

Purpose of the Study:

  • To identify hepatic and biliary autoantigens implicated in the pathogenesis of autoimmune CAH (A-CAH) and primary biliary cirrhosis (PBC).
  • To differentiate A-CAH from other forms of CAH using serological markers.
  • To characterize disease-specific autoantigens in PBC.

Main Methods:

  • Western immunoblotting using patient sera against liver autoantigen preparations.

Related Experiment Videos

  • Antibody screening of a rat liver gene expression library.
  • cDNA cloning to identify encoding sequences for autoantigens.

    • Main Results:

    • Serum reactivity in A-CAH and hepatitis B virus-related CAH showed similarities with liver preparations.
    • In A-CAH, multiple reactivities were observed with liver preparations, including hepatocyte membrane.
    • PBC sera exhibited reactivity against two disease-specific polypeptides (70 and 45 kD).
    • A cDNA clone encoded the antigenic site of the 70 kD polypeptide, identified as the E2 component of pyruvate dehydrogenase (PDH).

    Conclusions:

    • The 70 kD autoantigen in PBC is the E2 component of pyruvate dehydrogenase (PDH).
    • A specific decapeptide (residues 83-92) within the M2 component of PDH is a disease-specific autoepitope in PBC.
    • These findings contribute to understanding the autoimmune basis of PBC and A-CAH.